New data from LIBERTY studies show subcutaneous infliximab effectively restored and maintained disease control in Crohn's disease and ulcerative colitis patients after drug holiday of 16 weeks or more, with sustained efficacy through Week 102.
Researchers at Icahn School of Medicine at Mount Sinai found that major depressive disorder shares key immune abnormalities with atopic dermatitis, particularly Th2 pathway activation. The team plans to test dupilumab in a clinical trial for depression.
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT07601932 |
Patient Positioning for Treatment of Proximal Ureteral Stones |
RECRUITING | NA |
| NCT07600320 |
Fareon Open Label Device Clinical Trial |
NOT_YET_RECRUITING | NA |
| NCT07597902 |
SARS-CoV-2 and Herpesvirus Inhibition for Ending Long COVID Dysfunction |
NOT_YET_RECRUITING | PHASE2 |
| NCT07581158 |
Understanding and Targeting Self-Regulatory Control in Bulimia Nervosa |
NOT_YET_RECRUITING | NA |
| NCT07572175 |
Sotagliflozin as Prevention of Anthracycline-Related Cardiotoxicity |
NOT_YET_RECRUITING | PHASE2 |
| NCT07548385 |
Suzetrigine for Treatment and Reduction of Intense Discomfort After knEe Replacement PAIN |
RECRUITING | PHASE3 |
| NCT07542145 |
MDMA Assisted Therapy for BN |
NOT_YET_RECRUITING | PHASE1 |
| NCT07539623 |
Suzetrigine-enhanced MultimOdal Opioid-sparing THerapy in Cardiac and Bariatric SURGery |
RECRUITING | PHASE3 |
| NCT07539597 |
Innovative Approaches to Hypertension Management in High-Risk Emergency Department Populations |
RECRUITING | NA |
| NCT07510386 |
CGM After Discharge From Hospital |
NOT_YET_RECRUITING | NA |
